Neurizon Therapeutics Ltd

NEW
ASX:NUZ (Australia)  
A$ 0.072 +0.0020 (+2.86%) Jul 6
At Loss
P/B:
4.80
Market Cap:
A$ 54.98M ($ 38.19M)
Enterprise V:
A$ 48.68M ($ 33.81M)
Volume:
919.49K
Avg Vol (2M):
978.68K
Trade In:
Volume:
919.49K
At Loss
Avg Vol (2M):
978.68K

Neurizon Therapeutics Ltd (ASX:NUZ) Dividend

Neurizon Therapeutics Ltd (ASX:NUZ) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -15.8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:NUZ Dividend

Does Neurizon Therapeutics Ltd (ASX:NUZ) pay a dividend?

Neurizon Therapeutics Ltd (ASX:NUZ) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Neurizon Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Neurizon Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -15.8% over the past 3 years.

What are dividend-paying alternatives to Neurizon Therapeutics Ltd?

For dividend-paying alternatives in Neurizon Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.